Bei Jin
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 3
- Ubiquitin and proteasome pathways 2
- Cancer-related gene regulation 2
-
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- Jingxuan Pan (15 shared papers)Jingfeng Zhou (4 shared papers)Yanli Jin (6 shared papers)Ke Ding (3 shared papers)Xin Du (3 shared papers)Wei Dai (1 shared paper)Ping Zhang (2 shared papers)Yun Wang (2 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Theranostics (2 papers)Molecular Cancer (2 papers)Biochemical Pharmacology (1 paper)Carcinogenesis (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Bei Jin
15 papers receiving 586 citations
Peers
Comparison fields: 5 of 62
- Ophthalmology 96
- Hematology 88
- Geriatrics and Gerontology 26
- Molecular Biology 380
- Oncology 106
Countries citing papers authored by Bei Jin
This map shows the geographic impact of Bei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Jin more than expected).
Fields of papers citing papers by Bei Jin
This network shows the impact of papers produced by Bei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Jin. The network helps show where Bei Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Bei Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 134 | |
| 2 | 2016 | 71 | |
| 3 | 2017 | 56 | |
| 4 | 2016 | 54 | |
| 5 | 2017 | 50 | |
| 6 | 2012 | 43 | |
| 7 | 2020 | 43 | |
| 8 | 2014 | 37 | |
| 9 | 2015 | 32 | |
| 10 | 2016 | 28 | |
| 11 | 2024 | 16 | |
| 12 | 2023 | 11 | |
| 13 | 2018 | 8 | |
| 14 | 2024 | 4 | |
| 15 | 2023 | 3 |
About Bei Jin
Bei Jin is a scholar working on Molecular Biology, Hematology, Ophthalmology, Immunology and Pathology and Forensic Medicine, having authored 15 papers that have together received 590 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (4 papers), Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Ocular Oncology and Treatments (3 papers), Ubiquitin and proteasome pathways (2 papers), Mast cells and histamine (2 papers), Cancer-related gene regulation (2 papers) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Ophthalmology (96 citations), Hematology (88 citations), Geriatrics and Gerontology (26 citations), Molecular Biology (380 citations) and Oncology (106 citations). Bei Jin has collaborated with scholars based in China and United States. Frequent co-authors include Jingxuan Pan, Jingfeng Zhou, Yanli Jin, Ke Ding, Xin Du, Wei Dai, Ping Zhang, Yun Wang, Ruibao Ren and Fang Xu. Their work appears in journals such as Clinical Cancer Research, Theranostics, Molecular Cancer, Biochemical Pharmacology and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.